ConductScience.org, home

Gene · 2621

NIH grants2,018

NIH grants whose papers are about the gene, through NIH's grant-paper links.

561 to 580 of 2,018

Download this page as JSON
GrantTitleGAS6 papersNewest fiscal year
R01DK068437Postprandial Vitamin A12023
R01DK085259Sphingolipids in Acute Kidney Injury and Disease Progression12023
R01DK103818Notch, Type 2 Diabetes and NAFLD12023
R01DK103901Deciphering Ion Channel Mechanisms Underlying Mechanosensitivity in the Gut12023
R01DK109683Role of RTN1A in the Progression of Diabetic Nephropathy12023
R01ES024373YTHDF2 and UVB damage response in skin cancer12023
R01ES029925Genetic underpinning of diabetes associated with arsenic exposure12023
R01ES030576The mechanistic role of METTL14 in UVB-induced skin tumorigenesis12023
R01ES030950Environmental bisphenol exposure, infant brain and behavior: Human and animal models12023
R01EY023591Advanced Technology to Study Visual Function on a Cellular Scale12023
R01GM089778Proteolytic Control of Iron Metabolism by the E3 Ubiquitin Ligase FBXL512023
R01GM114141Mechanisms mediating immune response upon sensing of nuclear viral DNA12023
R01HL060917Nitric Oxide in Pulmonary Hypertension12023
R01HL123920Targeted Anti-IL-1β Platelet Mimetics for Cardiac Detoxification and Repair12023
R01HL126796Cardiac afferents and renal function in heart failure12023
R01HL130845Mechanisms regulating VEGF receptors in diabetic angiogenesis12023
R01HL146802Defining and targeting mechanisms of smoke-mediated fibrosis progression12023
R01HL148167Understanding the Molecular Mechanisms of Fibromuscular Dysplasia12023
R01HL151152Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care12023
R01HL151283Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial12023

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2621/grants?page=29